---
figid: PMC6675034__PO.17.00198app4
figlink: pmc/articles/PMC6675034/figure/fA.4/
number: AF4
caption: 'Full candidate pathway that represents molecular drivers of tumorigenesis
  in the sarcoma of patient 1. We reconstructed this pathway on the basis of the outlier
  analysis, differential gene expression analysis, copy number information and literature
  mining (Appendix Methods). A simplified version of this pathway is presented in
  . Both EWSR1-ATF1 and receptor tyrosine kinases PDGFRB, NTRK1, ALK, and FGFR1 can
  contribute to the activation of IL6/JAK/STAT3 signaling. All gene expression outliers
  depicted in this figure were significant in all three comparisons: patient 1 versus
  all cancers, patient 1 versus lung adenocarcinomas, and patient 1 versus sarcomas.
  JAK1, the molecular target of ruxolitinib, is indicated with a yellow lightning
  bolt. TCGA, The Cancer Genome Atlas.'
pmcid: PMC6675034
papertitle: Comparative RNA-Sequencing Analysis Benefits a Pediatric Patient With
  Relapsed Cancer.
reftext: Yulia Newton, et al. JCO Precis Oncol. 2018;2:PO.17.00198.
pmc_ranked_result_index: '11027'
pathway_score: 0.8462251
filename: PO.17.00198app4.jpg
figtitle: Full candidate pathway that represents molecular drivers of tumorigenesis
  in the sarcoma of patient 1
year: '2018'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6675034__PO.17.00198app4.html
  '@type': Dataset
  description: 'Full candidate pathway that represents molecular drivers of tumorigenesis
    in the sarcoma of patient 1. We reconstructed this pathway on the basis of the
    outlier analysis, differential gene expression analysis, copy number information
    and literature mining (Appendix Methods). A simplified version of this pathway
    is presented in . Both EWSR1-ATF1 and receptor tyrosine kinases PDGFRB, NTRK1,
    ALK, and FGFR1 can contribute to the activation of IL6/JAK/STAT3 signaling. All
    gene expression outliers depicted in this figure were significant in all three
    comparisons: patient 1 versus all cancers, patient 1 versus lung adenocarcinomas,
    and patient 1 versus sarcomas. JAK1, the molecular target of ruxolitinib, is indicated
    with a yellow lightning bolt. TCGA, The Cancer Genome Atlas.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EWSR1
  - ATF1
  - SH3RF1
  - SLC1A1
  - TOP2A
  - ARNT2
  - CALCA
  - CALCB
  - PTGS2
  - IL6
  - MMP1
  - AURKA
  - IL6R
  - NTRK1
  - ALK
  - PTEN
  - PIK3R2
  - AKT1
  - AK1
  - AKT3
  - JAK1
  - MTOR
  - CCND1
  - EIF4EBP1
  - BCL11B
  - BIRC5
  - ETS2
  - TCGA
  - O
  - sarcoma
  - lung adenocarcinoma cohort
  - cancer
genes:
- word: EWSR1
  symbol: EWSR1
  source: hgnc_symbol
  hgnc_symbol: EWSR1
  entrez: '2130'
- word: ΑTF1
  symbol: ATF1
  source: hgnc_symbol
  hgnc_symbol: ATF1
  entrez: '466'
- word: SH3RF1
  symbol: SH3RF1
  source: hgnc_symbol
  hgnc_symbol: SH3RF1
  entrez: '57630'
- word: SLC1A1
  symbol: SLC1A1
  source: hgnc_symbol
  hgnc_symbol: SLC1A1
  entrez: '6505'
- word: ТОP2A
  symbol: TOP2A
  source: hgnc_symbol
  hgnc_symbol: TOP2A
  entrez: '7153'
- word: ARNT2
  symbol: ARNT2
  source: hgnc_symbol
  hgnc_symbol: ARNT2
  entrez: '9915'
- word: CALCA
  symbol: CALCA
  source: hgnc_symbol
  hgnc_symbol: CALCA
  entrez: '796'
- word: CALCB
  symbol: CALCB
  source: hgnc_symbol
  hgnc_symbol: CALCB
  entrez: '797'
- word: PTGS2
  symbol: PTGS2
  source: hgnc_symbol
  hgnc_symbol: PTGS2
  entrez: '5743'
- word: IL6
  symbol: IL6
  source: hgnc_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: MMP1
  symbol: MMP1
  source: hgnc_symbol
  hgnc_symbol: MMP1
  entrez: '4312'
- word: AURKA
  symbol: AURKA
  source: hgnc_symbol
  hgnc_symbol: AURKA
  entrez: '6790'
- word: IL6R
  symbol: IL6R
  source: hgnc_symbol
  hgnc_symbol: IL6R
  entrez: '3570'
- word: NTRK1
  symbol: NTRK1
  source: hgnc_symbol
  hgnc_symbol: NTRK1
  entrez: '4914'
- word: ALK
  symbol: ALK
  source: hgnc_symbol
  hgnc_symbol: ALK
  entrez: '238'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: PIK3R2
  symbol: PIK3R2
  source: hgnc_symbol
  hgnc_symbol: PIK3R2
  entrez: '5296'
- word: АКТ1
  symbol: AKT1
  source: hgnc_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: АКТ1
  symbol: AK1
  source: hgnc_symbol
  hgnc_symbol: AK1
  entrez: '203'
- word: АКТЗ
  symbol: AKT3
  source: hgnc_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: JAK1
  symbol: JAK1
  source: hgnc_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: МTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: CCND1
  symbol: CCND1
  source: hgnc_symbol
  hgnc_symbol: CCND1
  entrez: '595'
- word: EIF4EBP1
  symbol: EIF4EBP1
  source: hgnc_symbol
  hgnc_symbol: EIF4EBP1
  entrez: '1978'
- word: BCL11B
  symbol: BCL11B
  source: hgnc_symbol
  hgnc_symbol: BCL11B
  entrez: '64919'
- word: BIRC5
  symbol: BIRC5
  source: hgnc_symbol
  hgnc_symbol: BIRC5
  entrez: '332'
- word: ETS2
  symbol: ETS2
  source: hgnc_symbol
  hgnc_symbol: ETS2
  entrez: '2114'
- word: ATF1
  symbol: ATF1
  source: hgnc_symbol
  hgnc_symbol: ATF1
  entrez: '466'
chemicals:
- word: TCGA
  source: MESH
  identifier: C047031
- word: O
  source: MESH
  identifier: D013481
diseases:
- word: sarcoma
  source: MESH
  identifier: D012509
- word: lung adenocarcinoma cohort
  source: MESH
  identifier: D000077192
- word: cancer
  source: MESH
  identifier: D009369
figid_alias: PMC6675034__AF4
redirect_from: /figures/PMC6675034__AF4
figtype: Appendix figure
---
